Maximus, Inc. $MMS Stock Position Reduced by Jefferies Financial Group Inc.

Jefferies Financial Group Inc. trimmed its position in Maximus, Inc. (NYSE:MMS) by 22.2% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 10,900 shares of the health services provider’s stock after selling 3,115 shares during the quarter. Jefferies Financial Group Inc.’s holdings in Maximus were worth $765,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds have also made changes to their positions in MMS. Caitong International Asset Management Co. Ltd boosted its holdings in Maximus by 17,533.3% in the first quarter. Caitong International Asset Management Co. Ltd now owns 529 shares of the health services provider’s stock worth $36,000 after purchasing an additional 526 shares during the period. UMB Bank n.a. boosted its holdings in shares of Maximus by 37.5% in the 2nd quarter. UMB Bank n.a. now owns 833 shares of the health services provider’s stock valued at $58,000 after buying an additional 227 shares during the period. Bayforest Capital Ltd acquired a new position in shares of Maximus in the 2nd quarter valued at about $61,000. Parkside Financial Bank & Trust grew its position in shares of Maximus by 21.7% during the 2nd quarter. Parkside Financial Bank & Trust now owns 879 shares of the health services provider’s stock valued at $62,000 after buying an additional 157 shares during the last quarter. Finally, GAMMA Investing LLC raised its stake in Maximus by 60.4% during the second quarter. GAMMA Investing LLC now owns 1,174 shares of the health services provider’s stock worth $82,000 after acquiring an additional 442 shares during the period. 97.21% of the stock is owned by institutional investors and hedge funds.

Insider Activity at Maximus

In other news, insider Michelle F. Link sold 1,610 shares of the company’s stock in a transaction that occurred on Wednesday, October 1st. The shares were sold at an average price of $90.86, for a total value of $146,284.60. Following the completion of the sale, the insider directly owned 13,508 shares of the company’s stock, valued at approximately $1,227,336.88. This represents a 10.65% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Company insiders own 1.60% of the company’s stock.

Maximus Stock Down 0.4%

Shares of Maximus stock opened at $86.30 on Friday. The company has a debt-to-equity ratio of 0.91, a current ratio of 2.27 and a quick ratio of 2.27. Maximus, Inc. has a 1-year low of $63.77 and a 1-year high of $92.50. The business’s fifty day moving average price is $85.73 and its two-hundred day moving average price is $79.91. The company has a market capitalization of $4.70 billion, a P/E ratio of 15.89 and a beta of 0.57.

Maximus (NYSE:MMS) last released its quarterly earnings results on Thursday, November 20th. The health services provider reported $1.62 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.63 by ($0.01). Maximus had a return on equity of 24.44% and a net margin of 5.83%.The business had revenue of $1.32 billion during the quarter, compared to the consensus estimate of $1.34 billion. During the same period in the previous year, the company posted $1.46 EPS. The company’s revenue for the quarter was up .2% compared to the same quarter last year. Maximus has set its FY 2026 guidance at 7.950-8.250 EPS. As a group, research analysts forecast that Maximus, Inc. will post 6.15 EPS for the current year.

Maximus Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Monday, December 1st. Shareholders of record on Friday, November 14th will be paid a dividend of $0.30 per share. The ex-dividend date of this dividend is Friday, November 14th. This represents a $1.20 annualized dividend and a yield of 1.4%. Maximus’s dividend payout ratio (DPR) is presently 21.58%.

Analyst Upgrades and Downgrades

Several analysts recently issued reports on MMS shares. Weiss Ratings reissued a “hold (c+)” rating on shares of Maximus in a report on Wednesday. Zacks Research lowered Maximus from a “strong-buy” rating to a “hold” rating in a research report on Monday, October 27th. One investment analyst has rated the stock with a Buy rating and two have issued a Hold rating to the company. Based on data from MarketBeat, the company has an average rating of “Hold” and a consensus price target of $90.00.

Maximus Company Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.